ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
The putative mechanisms underlying testosterone and cardiovascular risk
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 7822" data-attributes="member: 3"><p>A very well written short opinion article that summarizes factors that may increase cardiovascular risks of testosterone. All have been reviewed on ExcelMale.com but it is nice to see them summarized in a short paper by Dr Lipshultz' team. They did not include high estradiol as a causative factor, however.</p><p></p><p></p><p>[ATTACH]754[/ATTACH]</p><p></p><p>Maganty A, Kovac JR and Ramasamy R (2014) </p><p></p><p><strong>The putative mechanisms underlying testosterone and cardiovascular risk [v1; ref status: indexed, <a href="http://f1000r.es/374" target="_blank">http://f1000r.es/374</a>] <em>F1000Research 2014, <strong>3:87 </strong></em></strong></p><p><strong><em><strong></strong></em></strong></p><p><strong>Abstract</strong></p><p></p><p>The use of testosterone supplementation therapy (TST) is increasing primarily in men with symptomatic hypogonadism. While TST has been shown to have numerous benefits, as its use increases, the role on cardiovascular health must be explored. Previous evidence showed no adverse cardiovascular risks associated with TST use; however, more recent studies suggest that there may be an associated risk. The exact mechanism by which TST may contribute to cardiovascular risk has not been elucidated. Numerous mechanisms have been proposed which include testosterone's effect on thromboxane A2 receptors, vascular adhesion molecule 1 receptors, erythropoiesis, and obstructive sleep apnea, all of which can ultimately lead to atherogenesis and increased cardiovascular risk.</p><p></p><p>Quote:</p><p></p><p> This study's conclusions were similar to that previously discussed, in that men with a hematocrit greater than 50% were 1.8 times (1.1&#8211;2.7) more likely to die from CHD compared with men with a hematocrit of less than 50% after adjusting for coronary risk factors<a href="http://f1000research.com/articles/3-87/v1#ref-13" target="_blank">13</a>.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 7822, member: 3"] A very well written short opinion article that summarizes factors that may increase cardiovascular risks of testosterone. All have been reviewed on ExcelMale.com but it is nice to see them summarized in a short paper by Dr Lipshultz' team. They did not include high estradiol as a causative factor, however. [ATTACH=CONFIG]754[/ATTACH] Maganty A, Kovac JR and Ramasamy R (2014) [B]The putative mechanisms underlying testosterone and cardiovascular risk [v1; ref status: indexed, [URL]http://f1000r.es/374[/URL]] [I]F1000Research 2014, [B]3:87 [/B][/I][/B] [B]Abstract[/B] The use of testosterone supplementation therapy (TST) is increasing primarily in men with symptomatic hypogonadism. While TST has been shown to have numerous benefits, as its use increases, the role on cardiovascular health must be explored. Previous evidence showed no adverse cardiovascular risks associated with TST use; however, more recent studies suggest that there may be an associated risk. The exact mechanism by which TST may contribute to cardiovascular risk has not been elucidated. Numerous mechanisms have been proposed which include testosterone's effect on thromboxane A2 receptors, vascular adhesion molecule 1 receptors, erythropoiesis, and obstructive sleep apnea, all of which can ultimately lead to atherogenesis and increased cardiovascular risk. Quote: This study's conclusions were similar to that previously discussed, in that men with a hematocrit greater than 50% were 1.8 times (1.1–2.7) more likely to die from CHD compared with men with a hematocrit of less than 50% after adjusting for coronary risk factors[URL="http://f1000research.com/articles/3-87/v1#ref-13"]13[/URL]. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
The putative mechanisms underlying testosterone and cardiovascular risk
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top